N6-methyladenine regulates mitochondrial function and its research progress in metabolic diseases
CSTR:
Author:
Affiliation:

1.Institute of Translational Medicine, Hengyang Medical College, University of South China, Hengyang, Hunan 421001, China;2.Guangxi Key Laboratory of Diabetic Systems Medicine, Guilin Medical University, Guilin, Guangxi 541100, China)

Clc Number:

R365;R5

  • Article
  • | |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • | |
  • Comments
    Abstract:

    N6-methyladenine (6mA) is an epigenetic modification existed in eukaryotes, which dynamically regulates transcription by modifying mitochondrial DNA, non-coding genes and ribosomal DNA. Current studies have found that 6mA affects mitochondrial activity and function by regulating mitochondrial DNA transcription, etc., and then participates in the occurrence and development of metabolic diseases. This paper discusses the mechanism of 6mA regulating mitochondrial function and its role in metabolic diseases such as obesity, atherosclerosis, hypertension and cancer, which is expected to provide new ideas for the prevention and treatment of metabolic-related diseases.

    Reference
    Related
    Cited by
Get Citation

YANG Min, LIU Jiaqi, ZHU Xiao, JIANG Xiaping, YANG Siqi, YIN Kai, GUI Qingjun. N6-methyladenine regulates mitochondrial function and its research progress in metabolic diseases[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2022,30(5):442-448.

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:December 26,2021
  • Revised:March 25,2022
  • Online: May 10,2022
Article QR Code